ADMA Biologics CEO Adam Grossman's 2019 pay rises 10% to $1.7M
ADMA Biologics reports 2019 executive compensation
By ExecPay News
Published: April 29, 2020
ADMA Biologics reported fiscal year 2019 executive compensation information on April 29, 2020.
In 2019, three executives at ADMA Biologics received on average a compensation package of $1.4M, a 15% increase compared to previous year.
Average pay of disclosed executives at ADMA Biologics
Adam S. Grossman, Chief Executive Officer, received $1.7M in total, which increased by 10% compared to 2018. 45% of Grossman's compensation, or $761K, was in option awards. Grossman also received $369K in bonus, $536K in salary, as well as $37K in other compensation.
James Mond, Chief Scientific Officer, received a compensation package of $1.2M, which increased by 18% compared to previous year. 34% of the compensation package, or $415K, was in salary.
Brian Lenz, Chief Financial Officer, earned $1.1M in 2019, a 19% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 29, 2020.